[go: up one dir, main page]

NO20035146D0 - Granul¶re preparater av gaboksadol - Google Patents

Granul¶re preparater av gaboksadol

Info

Publication number
NO20035146D0
NO20035146D0 NO20035146A NO20035146A NO20035146D0 NO 20035146 D0 NO20035146 D0 NO 20035146D0 NO 20035146 A NO20035146 A NO 20035146A NO 20035146 A NO20035146 A NO 20035146A NO 20035146 D0 NO20035146 D0 NO 20035146D0
Authority
NO
Norway
Prior art keywords
gaboxadol
granular preparations
granular
preparations
Prior art date
Application number
NO20035146A
Other languages
English (en)
Other versions
NO20035146L (no
Inventor
Michiel Onne Elema
Lene Andresen
Per Holm
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of NO20035146L publication Critical patent/NO20035146L/no
Publication of NO20035146D0 publication Critical patent/NO20035146D0/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO20035146A 2001-05-21 2003-11-19 Granul¶re preparater av gaboksadol NO20035146D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200100817 2001-05-21
PCT/DK2002/000332 WO2002094225A1 (en) 2001-05-21 2002-05-17 Granular preparations of gaboxadol

Publications (2)

Publication Number Publication Date
NO20035146L NO20035146L (no) 2003-11-19
NO20035146D0 true NO20035146D0 (no) 2003-11-19

Family

ID=8160520

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20035146A NO20035146D0 (no) 2001-05-21 2003-11-19 Granul¶re preparater av gaboksadol

Country Status (26)

Country Link
US (1) US20040157876A1 (no)
EP (1) EP1389091A1 (no)
JP (1) JP2004530695A (no)
KR (1) KR20030097890A (no)
CN (1) CN1511026A (no)
AR (1) AR033896A1 (no)
AU (1) AU2002338855B2 (no)
BG (1) BG108441A (no)
BR (1) BR0209834A (no)
CA (1) CA2447603A1 (no)
CZ (1) CZ20033269A3 (no)
EA (2) EA009731B1 (no)
HR (1) HRP20030950A2 (no)
HU (1) HUP0400051A2 (no)
IL (1) IL158733A0 (no)
IS (1) IS7020A (no)
ME (1) MEP6308A (no)
MX (1) MXPA03010596A (no)
NO (1) NO20035146D0 (no)
NZ (1) NZ547636A (no)
PL (1) PL366541A1 (no)
SK (1) SK15542003A3 (no)
UA (1) UA80092C2 (no)
WO (1) WO2002094225A1 (no)
YU (1) YU92103A (no)
ZA (1) ZA200308594B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1220658A1 (en) * 1999-09-28 2002-07-10 H. Lundbeck A/S Melt granulated composition and modified release dosage form prepared from said composition
AU2004248890A1 (en) 2003-06-25 2004-12-29 H. Lundbeck A/S Gaboxadol for treating depression and other affective disorders
TW200528098A (en) * 2003-12-18 2005-09-01 Lundbeck & Co As H Treatment of insomnia in human patients
GB0402118D0 (en) 2004-01-30 2004-03-03 Merck Sharp & Dohme Polymorphic forms of a GABAA agonist
WO2006083682A2 (en) 2005-01-28 2006-08-10 H.Lundbeck A/S Polymorphic forms of a gabaa agonist
US20080262029A1 (en) * 2005-04-29 2008-10-23 H. Lundbeck A/S Acid and Base Salt Forms of Gaboxadol
WO2009148891A1 (en) * 2008-05-30 2009-12-10 Psychogenics, Inc. Treatment for neurological and mental disorders
EP2334299A1 (en) * 2008-09-01 2011-06-22 H. Lundbeck A/S Pharmaceutical composition comprising gaboxadol and an inhibitor of patl or oat
CA2859174C (en) * 2011-12-12 2019-03-05 Orbis Biosciences, Inc. Sustained release particle formulations
IL256912B2 (en) 2015-07-17 2024-01-01 Ovid Therapeutics Inc Methods of treating developmental disorders with gaboxadol

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4315934A (en) * 1979-09-24 1982-02-16 Sandoz Ltd. Organic compounds
DE19525598C2 (de) * 1995-07-13 1997-09-25 Max Planck Gesellschaft Schlafmittel
US6649186B1 (en) * 1996-09-20 2003-11-18 Ethypharm Effervescent granules and methods for their preparation
EP1220658A1 (en) * 1999-09-28 2002-07-10 H. Lundbeck A/S Melt granulated composition and modified release dosage form prepared from said composition
US6375982B1 (en) * 2000-07-05 2002-04-23 Capricorn Pharma, Inc. Rapid-melt semi-solid compositions, methods of making same and method of using same

Also Published As

Publication number Publication date
UA80092C2 (en) 2007-08-27
IL158733A0 (en) 2004-05-12
EA009731B1 (ru) 2008-02-28
EP1389091A1 (en) 2004-02-18
CA2447603A1 (en) 2002-11-28
BR0209834A (pt) 2004-06-15
HUP0400051A2 (hu) 2004-04-28
SK15542003A3 (sk) 2004-05-04
KR20030097890A (ko) 2003-12-31
WO2002094225A1 (en) 2002-11-28
NO20035146L (no) 2003-11-19
US20040157876A1 (en) 2004-08-12
YU92103A (sh) 2006-05-25
AR033896A1 (es) 2004-01-07
JP2004530695A (ja) 2004-10-07
CN1511026A (zh) 2004-07-07
AU2002338855B2 (en) 2007-08-16
BG108441A (en) 2005-02-28
HRP20030950A2 (en) 2005-08-31
CZ20033269A3 (en) 2004-03-17
IS7020A (is) 2003-11-10
ZA200308594B (en) 2004-11-04
PL366541A1 (en) 2005-02-07
MEP6308A (xx) 2010-02-10
MXPA03010596A (es) 2004-03-09
NZ547636A (en) 2008-03-28
EA200700703A1 (ru) 2007-08-31
EA200301282A1 (ru) 2004-04-29

Similar Documents

Publication Publication Date Title
NO20042680L (no) Fremgangsmater for fremstilling av O-demetylvenflaxine
NO20035087D0 (no) Anvendelse av HMG fragment som anti-inflammatoriske midler
DK1326864T3 (da) Sammenföjede aryl- eller heteroarylforbindelser som antiinflammatoriske og analgetiske midler
NO20033203D0 (no) Terapeutiske heterocykliske forbindelser
NO20035193L (no) Nye pyrrolderivater som farmas degree ytiske midler
NO20034439D0 (no) Benzamidinderivater
ATE319451T1 (de) Tetrahydrochinolin-derivate
ATE312827T1 (de) 3-substituierte-4-pyrimidonderivate
NO20044916L (no) Preparater av sulfinylacetamid
NO20040253L (no) Fremgangsmater for behandling av leverfibroser
NO20033205D0 (no) Terapeutiske kromanforbindelser
NO20013507L (no) Blandinger for behandling av inflammatoriske reaksjoner
ATE459598T1 (de) Sulfonamidderivate
NO20040278L (no) Fremgangsmate for fremstilling av perindopril
EE200300447A (et) Asendatud bensofuraan-2-karboksamiidide derivaadid
DE50209070D1 (de) Sämaschine
NO20035146D0 (no) Granul¶re preparater av gaboksadol
NO20041968L (no) Anvendelse av cystationin
NO20044814L (no) Fremgangsmate for fremstilling av combretastaniner
DE60223468D1 (de) Gel-ummanteltes Saatgut
NO20042640L (no) Fremgangsmate for fremstilling av ekinocandinderivater
DE60212694D1 (de) Benzothiazolderivaten
ATE382601T1 (de) Substituierte 4-aminocyclohexanolderivate
NO20012612L (no) Isonipecotamider for behandlingen av integrin-formidlede sykdommer
DE60202381D1 (de) Paroxetin-n-formyl-derivate

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104

FC2A Withdrawal, rejection or dismissal of laid open patent application